Veraxa Biotech AG

VRXAW·NasdaqCM
Compare
0.0290−0.0012 (−3.97%)today
At close: Nov 4, 4:00 PM EST · May be delayed up to 15 min · USD

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close0.0302
Open0.0302
Day range0.02900.0302
52-week range0.02960.0302
Off day high−3.97%
Off 52-week high−3.97%
Volume8.88K
Avg. volume (3M)—
Market cap—
EPS (TTM)—
Forward P/E—
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)0.22
Shares outstanding—
Short interest—
Earnings date—
Analyst target—
Profit margin0.00%

Against its peers

Compare in full ›
VRXAW CTMX 3378.HK HURA 1873.HK ATORX.ST
Market cap — 512.06M 3.73B 109.61M 2.80B 38.18M
P/E (TTM) — — — — 16.9 —
Forward P/E — -5.0 — -2.8 6.2 -0.1
Price/book 0.0 1.7 5.1 6.0 0.6 0.3
Dividend yield — — — — — —
1-year change — −43.91% +54.07% −29.80% −43.17% −99.44%
Today −3.97% +7.80% +5.13% +3.93% +5.04% 0.00%

The closest companies by business. Prices may be delayed up to 15 min.

Related companies

Compare ›

The businesses closest to Veraxa Biotech's by what they do, from their descriptions, with the same industry weighted in.

Company Mkt cap Price Today
CytomX Therapeutics, Inc.CTMX · Biotechnology 512.06M 2.3500 +7.80%
Hanx Biopharmaceuticals (Wuhan) Co., Ltd.3378.HK · Biotechnology 3.73B 27.860 +5.13%
TuHURA Biosciences, Inc.HURA · Biotechnology 109.61M 1.7200 +3.93%
Viva Biotech Holdings1873.HK · Biotechnology 2.80B 1.355 +5.04%
Alligator Bioscience AB (publ)ATORX.ST · Biotechnology 38.18M 0.0107 0.00%
MacroGenics, Inc.MGNX · Biotechnology 147.15M 2.3100 −0.86%
Zymeworks Inc.ZYME · Biotechnology 2.22B 30.94 +2.69%
Vera Therapeutics, Inc.VERA · Biotechnology 2.30B 31.97 +4.10%

What visitors to Veraxa Biotech's page also look at.

Company Mkt cap Price Today
Veraxa Biotech AGVRXA 134.34M 0.9500 −4.04%
Launch One Acquisition Corp. WaLPAAW — 0.0402 0.00%
Hadron Energy, Inc.HDRNW — 0.0725 −4.86%
Namib Minerals WarrantsNAMMW — 0.1520 +38.18%
Dynamix CorporationDYNCW — 0.0036 −89.71%

From the 4SEARCH.business instruments index: what each company does (its business description), its industry, size, headquarters and the markets it serves; and from a year of daily prices, which move together. Prices may be delayed up to 20 min.

Latest news

All VRXAW news ›
MarketScreener··2 outletsPositive

VERAXA Biotech AG And OmniAb, Inc. Advance Bispecific Antibody Drug Conjugate Program VXA-222 From Joint Discovery Collaboration

VERAXA Biotech AG announced the advancement of bispecific ADC program VXA-222, following successful achievement of a key technical milestone in its alliance with OmniAb, Inc. The program is moving... VERAXA Biotech AG announced the…

VRXASNY
More from 1 other outlet
MissionIR··3 outletsPositive

VERAXA Biotech AG (NASDAQ: VRXA) Expands Human-Relevant Testing Strategy to Advance Antibody-Based Cancer Pipeline

VERAXA Biotech (NASDAQ: VRXA), an emerging leader in designing novel cancer therapies, is expanding its use of human-relevant testing methods across its oncology research programs, seeking to generate more clinically informative…

VRXAGOOGL
More from 2 other outlets
NewMediaWire··3 outletsPositive

VERAXA Biotech (VRXA) Presents First In Vivo Proof-of-Concept Data for BiTAC-ADC Platform at World ADC Congress

LOS ANGELES, CA - October 13, 2026 (NEWMEDIAWIRE) - VERAXA Biotech (NASDAQ: VRXA), an emerging leader in designing novel cancer therapies, presented its first in vivo proof-of-concept data and additional in vitro findings validating its…

VRXA
More from 2 other outlets

From the 4Search news index, newest first.

In the news

17mentions in 30 days
17with it in the headline
Positivesentiment

Mentioned with

U.S. Food and Drug Administration13European Molecular Biology Laboratory10Veraxa10Veraxa Biotech AG10Astrazeneca9Sanofi9Twitter9Veraxa Biotech Gmbh9

People in the coverage

Bluesky11Christoph Erkel10Bel?N Garijo5Belen Garijo5Dupixent5George D Yancopoulos5

Themes

Cancer10Vrxa10Oncology9Adc8Finanzen8FDA7Oncodaily7Biotech6

Most coverage from

  1. markets.businessinsider.com6
  2. investors.veraxa.com3
  3. manilatimes.net2
  4. marketscreener.com2
  5. tradingview.com2

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 17 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance